A detailed history of Cornerstone Investment Partners, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Cornerstone Investment Partners, LLC holds 11,250 shares of NEO stock, worth $191,025. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,250
Previous 10,910 3.12%
Holding current value
$191,025
Previous $151,000 9.27%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$13.4 - $17.73 $4,556 - $6,028
340 Added 3.12%
11,250 $165,000
Q2 2024

Aug 12, 2024

BUY
$13.01 - $15.77 $141,939 - $172,050
10,910 New
10,910 $151,000
Q1 2020

Apr 27, 2020

SELL
$20.5 - $34.53 $206,660 - $348,096
-10,081 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$18.96 - $29.84 $191,135 - $300,817
10,081 New
10,081 $295,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.14B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.